SeraCare Life Sciences-SRLS announces internal review by audit committee
SRLS says its auditor raises concerns on revenue recognition policies and concerns on inventory valuation. SRLS expects to release Q4 results when the review is done and is in talks with lenders for waivers on filing delay. SRLS has also postponed its shareholder meeting and says that the Nasdaq may initiate delisting procedures.
09:03 EDT SeraCare Life Sciences-SRLS delays filing Form 10-K for year ending Sept 30, 2005 SRLS expects to file its Form 10-K by December 15, 2005
Know how to make God laugh? Tell Her your plans ....